Madrigal Pharmaceuticals, Inc.
NasdaqGS:MDGL
$ 193.33
$0.00 (0.00%)
$ 193.33
$0.00 (0.00%)
End-of-day quote: 04/27/2024

MDGL - Madrigal Pharmaceuticals Stock Prediction 2025 - 2030

8 years of reliable Madrigal Pharmaceuticals stock forecast. The Wall Street analysts predict Outperform for MDGL. See at a glance whether NasdaqGS:MDGL will rise in the future.

$0.00
Forecast 2023
$231.22
Forecast 2025
$392.96
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
$0.00
Forecast 2025
$231.22
Forecast 2030
$392.96
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
-0.44
Price-to-book Ratio
9.48
Market Cap
5.01B
TEV
4.49 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$315.92

Madrigal Pharmaceuticals Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Madrigal Pharmaceuticals Stock Forecast 2023

$390.00

In the last five quarters, Madrigal Pharmaceuticals’s Price Target has risen from $127.70 to $315.92 - a 147.39% increase. Eleven analysts predict that Madrigal Pharmaceuticals’s share price will increase in the coming year, reaching $390.00. This would represent an increase of 23.45%.

101.73%
101.73
Last update: 04/27/2024

Highest Price Target $565.00

Average Price Target $390.00

Lowest Price Target $150.00

Madrigal Pharmaceuticals Stock Forecast 2025

Stock Prediction for the Price of One Madrigal Pharmaceuticals Share in Jan 2025.

In Jan 2025 analysts predict a share price of $209.89. An increase of 8.56% compared to today's share price.

Stock Prediction for the Price of One Madrigal Pharmaceuticals Share in Feb 2025.

In Feb 2025 analysts predict a share price of $211.83. An increase of 9.57% compared to today's share price.

Stock Prediction for the Price of One Madrigal Pharmaceuticals Share in Mar 2025.

In Mar 2025 analysts predict a share price of $213.77. An increase of 10.57% compared to today's share price.

Stock Prediction for the Price of One Madrigal Pharmaceuticals Share in Apr 2025.

In Apr 2025 analysts predict a share price of $215.71. An increase of 11.57% compared to today's share price.

Stock Prediction for the Price of One Madrigal Pharmaceuticals Share in May 2025.

In May 2025 analysts predict a share price of $217.64. An increase of 12.58% compared to today's share price.

Stock Prediction for the Price of One Madrigal Pharmaceuticals Share in Jun 2025.

In Jun 2025 analysts predict a share price of $219.58. An increase of 13.58% compared to today's share price.

Stock Prediction for the Price of One Madrigal Pharmaceuticals Share in Jul 2025.

In Jul 2025 analysts predict a share price of $221.52. An increase of 14.58% compared to today's share price.

Stock Prediction for the Price of One Madrigal Pharmaceuticals Share in Aug 2025.

In Aug 2025 analysts predict a share price of $223.46. An increase of 15.59% compared to today's share price.

Stock Prediction for the Price of One Madrigal Pharmaceuticals Share in Sep 2025.

In Sep 2025 analysts predict a share price of $225.40. An increase of 16.59% compared to today's share price.

Stock Prediction for the Price of One Madrigal Pharmaceuticals Share in Oct 2025.

In Oct 2025 analysts predict a share price of $227.34. An increase of 17.59% compared to today's share price.

Stock Prediction for the Price of One Madrigal Pharmaceuticals Share in Nov 2025.

In Nov 2025 analysts predict a share price of $229.28. An increase of 18.59% compared to today's share price.

Stock Prediction for the Price of One Madrigal Pharmaceuticals Share in Dec 2025.

In Dec 2025 analysts predict a share price of $231.22. An increase of 19.6% compared to today's share price.

Madrigal Pharmaceuticals Stock Predictions 2030

Madrigal Pharmaceuticals Stock Predictions for Jan 2030.

In January 2030 analysts predict a stock price of $356.71. An increase of 84.51% compared to the previous month's estimate.

Madrigal Pharmaceuticals Stock Predictions for Feb 2030.

In February 2030 analysts predict a stock price of $360.01. An increase of 86.21% compared to the previous month's estimate.

Madrigal Pharmaceuticals Stock Predictions for Mar 2030.

In March 2030 analysts predict a stock price of $363.30. An increase of 87.92% compared to the previous month's estimate.

Madrigal Pharmaceuticals Stock Predictions for Apr 2030.

In April 2030 analysts predict a stock price of $366.60. An increase of 89.62% compared to the previous month's estimate.

Madrigal Pharmaceuticals Stock Predictions for May 2030.

In May 2030 analysts predict a stock price of $369.89. An increase of 91.33% compared to the previous month's estimate.

Madrigal Pharmaceuticals Stock Predictions for Jun 2030.

In June 2030 analysts predict a stock price of $373.19. An increase of 93.03% compared to the previous month's estimate.

Madrigal Pharmaceuticals Stock Predictions for Jul 2030.

In July 2030 analysts predict a stock price of $376.48. An increase of 94.74% compared to the previous month's estimate.

Madrigal Pharmaceuticals Stock Predictions for Aug 2030.

In August 2030 analysts predict a stock price of $379.78. An increase of 96.44% compared to the previous month's estimate.

Madrigal Pharmaceuticals Stock Predictions for Sep 2030.

In September 2030 analysts predict a stock price of $383.08. An increase of 98.15% compared to the previous month's estimate.

Madrigal Pharmaceuticals Stock Predictions for Oct 2030.

In October 2030 analysts predict a stock price of $386.37. An increase of 99.85% compared to the previous month's estimate.

Madrigal Pharmaceuticals Stock Predictions for Nov 2030.

In November 2030 analysts predict a stock price of $389.67. An increase of 101.56% compared to the previous month's estimate.

Madrigal Pharmaceuticals Stock Predictions for Dec 2030.

In December 2030 analysts predict a stock price of $392.96. An increase of 103.26% compared to the previous month's estimate.

P/E
0.00
Beta
-0.44
Price-to-book Ratio
9.48
Market Cap
5.01B
TEV
4.49 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$315.92

Madrigal Pharmaceuticals Analyst Ratings Frequently Asked Questions

Who are the analysts watching Madrigal Pharmaceuticals, Inc.?

The following analysts have recently covered Madrigal Pharmaceuticals:

B. Riley Securities, Inc.
Canaccord Genuity
Evercore ISI
Goldman Sachs
H.C. Wainwright & Co.
Jefferies LLC
JMP Securities
Leerink Partners LLC
LifeSci Capital, LLC
Marktfeld
Oppenheimer & Co. Inc.
Piper Sandler Companies
Raymond James & Associates
TD Cowen
UBS Investment Bank
Citigroup Inc
Citigroup Inc. Research
CGS International
BofA Global Research
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Madrigal Pharmaceuticals, Inc.?

The following sell-side analysts have recently covered Madrigal Pharmaceuticals:

Mamtani, Mayank
Nash, Edward Hamilton
Seedhouse, Steven James
Bayko, Liisa Ann
Arce, Antonio Eduardo
Tewari, Akash
Wolleben, Jonathan Patrick
Smith, Thomas Jonathan
Paraskevopoulos, Michail
Olson, Jay
Rahimi, Yasmeen
Baral, Ritu Subhalaksmi
Katkhuda, Rami Azeez
Merle, Eliana Rachel
Lebowitz, David Neil
Tan, Andrea R.
Hammond, Alexandria
(This information refers to the last 90 days.)